IRMD - IRADIMED CORP

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 44.7

Open

$ 44.48

Bid

$ 0.00 x 0

Ask

$ 44.72 x 200

Day's Range

$ 43.97 - $ 44.89

52 Week Range

$ 35.62 - $ 50.33

Volume

61,721

Average Volume

Market Cap

569.92M

Beta (5Y Monthly)

$ 0.86

PE Ratio (TTM)

$ 31.80

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.03)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	03-01-2024	12-31-2023	10-K
3	11-03-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	03-02-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-05-2022	06-30-2022	10-Q
9	05-06-2022	03-31-2022	10-Q
10	03-04-2022	12-31-2021	10-K
11	11-05-2021	09-30-2021	10-Q
12	08-06-2021	06-30-2021	10-Q
13	05-07-2021	03-31-2021	10-Q
14	03-05-2021	12-31-2020	10-K
15	11-06-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	03-06-2020	12-31-2019	10-K
19	11-07-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-08-2019	03-31-2019	10-Q
22	03-07-2019	12-31-2018	10-K
23	11-07-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	03-08-2018	12-31-2017	10-K
27	11-06-2017	09-30-2017	10-Q
28	08-04-2017	06-30-2017	10-Q
29	05-05-2017	03-31-2017	10-Q
30	03-10-2017	12-31-2016	10-K
31	11-04-2016	09-30-2016	10-Q
32	08-05-2016	06-30-2016	10-Q
33	05-06-2016	03-31-2016	10-Q
34	03-10-2016	12-31-2015	10-K
35	11-10-2015	09-30-2015	10-Q
36	08-11-2015	06-30-2015	10-Q
37	05-11-2015	03-31-2015	10-Q
38	03-23-2015	12-31-2014	10-K
39	11-13-2014	09-30-2014	10-Q
40	08-14-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

IRADIMED Expects Q2 Adjusted EPS Of $1.52-...
05/02/2024 12:41:09

IRADIMED Expects 2024 Revenues Of $72M-$74...
05/02/2024 12:40:52

IRADIMED Expects Q2 Adjusted EPS Of $0.36 ...
05/02/2024 12:40:43

IRADIMED Expects Q2 Revenues Of $17.6M-$17...
05/02/2024 12:40:35

iRadimed Q1 2024 Adj EPS $0.36 Beats $0.34...
05/02/2024 12:35:18

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.34 by 5.8...

Roth MKM Reinstates Buy on iRadimed, Annou...
04/22/2024 13:19:59

Roth MKM analyst Jason Wittes reinstates iRadimed (NASDAQ:IRMD) with a Buy and announces $65 price target.

Iradimed Corp Files For Offering Of Common...
04/03/2024 20:30:53

- SEC Filing

IRadimed Forecasts FY24 Revenue of $72M-$7...
02/08/2024 13:10:07

IRadimed Forecasts Q1 FY24 Revenue of $17M...
02/08/2024 13:08:49

iRadimed Q4 Adjusted EPS $0.39 Misses $0.4...
02/08/2024 13:06:40

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.40 by 2...

Earnings Scheduled For February 8, 2024
02/08/2024 09:43:03

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

iRadimed's Earnings Outlook
02/07/2024 18:02:12

IRADIMED CORPORATION Reports Unaudited Q4 ...
01/09/2024 13:38:37

Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADI...

wednesday-is-your-last-chance-to-buy-iradimed-before-the-dividend-payout

Wednesday Is Your Last Chance To Buy iRadi...
12/18/2023 14:45:20

IRADIMED Sees FY23 Adjusted EPS Of $1.48-$...
11/03/2023 12:09:59

IRADIMED Sees FY23 Revenue Of $65.0M-$65.5...
11/03/2023 12:08:26

IRADIMED Sees Q4 FY23 Adjusted EPS Of $0.3...
11/03/2023 12:05:22

IRADIMED Sees Q4 FY23 Revenue Of $16.9M-$1...
11/03/2023 12:04:28

iRadimed Q3 Adjusted EPS $0.43 Beats $0.36...
11/03/2023 12:02:04

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.36 by 19....

Earnings Scheduled For November 3, 2023
11/03/2023 11:12:01

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per ...